Controversies in COVID-19 pandemic: the case of convalescent plasma

From Top Italian Scientists Journal
Revision as of 07:47, 6 June 2024 by Admin (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Published
June 5, 2024
Title
Controversies in COVID-19 pandemic: the case of convalescent plasma
Authors
Massimo Franchini, Daniele Focosi.
DOI
10.62684/TKSZ2015
Keywords
COVID-19; pandemic; therapy; convalescent plasma
Downloads
Download PDF
Download PDF

Massimo Franchini(a), Daniele Focosi(b).

(a) Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy;

(b) North-Western Tuscany Blood Bank, Pisa University Hospital, Italy.

Correspondence to: Massimo Franchini, MD; Department of Hematology and Transfusion Medicine; Carlo Poma Hospital, Mantova, Italy; E-mail: massimo.franchini@asst-mantova.it ; Phone: 0039-0376-201234 ; FAX: 0039-0376-220144

Abstract

The SARS-CoV-2 pandemic has caused an unprecedented health and social crisis worldwide. In this paper we summarized the different therapeutic actions planned from the two sides of the Atlantic Ocean (USA and Europe) to fight the initial phase of COVID-19 pandemic, with an emphasis on passive immunotherapies such as convalescent plasma and anti-Spike monoclonal antibodies. The lessons derived from the critical analysis of that period could drive our treatment decisions for the next pandemics.

Declarations

Conflict of Interest

The Authors declare that there is no conflict of interest.

References

  1. WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed on February 5, 2024.
  2. Yuan, Y., Jiao, B., Qu, L., Yang, D., & Liu, R. The development of COVID-19 treatment. Frontiers in Immunology. 2023; 14, 1125246. https://doi.org/10.3389/fimmu.2023.1125246
  3. Casadevall, A., & Pirofski LA. The convalescent sera option for containing COVID-19. Journal of Clinical Investigation. 2020; 130(4), 1545-1548. https://doi.org/10.1172/JCI138003
  4. Senefeld, J.W., Franchini, M., Mengoli, C., Cruciani, M., Zani, M., Gorman, E.K., Focosi, D., Casadevall, A., & Joyner, M.J. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis. JAMA Network Open. 2023; 6(1), e2250647. https://doi.org/10.1001/jamanetworkopen.2022.50647
  5. Senefeld, J.W., Gorman, E.K., Johnson, P.W., Moir, M.E., Klassen, S.A., Carter, R.E., Paneth, N.S., Sullivan, D.J., Morkeberg, O.H., Wright, R.S., Fairweather, D., Bruno, K.A., Shoham, S., Bloch, E.M., Focosi, D., Henderson, J.P., Juskewitch, J.E., Pirofski, L.A., Grossman, B.J., ., & Joyner, M.J. Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis. Mayo Clinic Proceedings Innovative Quality Outcomes. 2023; 7(5), 499-513. https://doi.org/ 10.1016/j.mayocpiqo.2023.09.001
  6. Bloch, E.M., Focosi, D., Shoham, S., Senefeld, J., Tobian, A.A.R., Baden, L.R., Tiberghien, P., Sullivan, D.J., Cohn, C., Dioverti, V., Henderson, J.P., So-Osman, C., Juskewitch, J.E., Razonable, R.R., Franchini, M., Goel, R., Grossman, B.J., Casadevall, A., Joyner, M.J., …, & Gebo, K.A. Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019. Clinical Infectious Diseases. 2023; 76(11), 2018-2024. https://doi.org/10.1093/cid/ciad066
  7. Hassan, S., West, K.A., Conry-Cantilena, K., & De Giorgi, V. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States. Transfusion. 2022; 62(2), 483-492. https://doi.org/10.1111/trf.16751
  8. Joyner, M.J., Bruno, K.A., Klassen, S.A., Kunze, K.L., Johnson, P.W., Lesser, E.R., Wiggins, C.C., Senefeld, J.W., Klompas, A.M., Hodge, D.O., Shepherd, J.R.A., Rea, R.F., Whelan, E.R., Clayburn, A.J., Spiegel, M.R., Baker, S.E., Larson, K.F., Ripoll, J.G., Andersen, K.J., … & Wright RS. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clinic Proceedings. 2020; 95(9), 1888-1897. https://doi.org/10.1016/j.mayocp.2020.06.028
  9. Casadevall, A., Dragotakes, Q., Johnson, P.W., Senefeld, J.W., Klassen, S.A., Wright, R.S., Joyner, M.J., Paneth, N., & Carter, R.E. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality. Elife. 2021; 10, e69866. htpps://doi.org/10.7554/eLife.69866.
  10. Franchini, M., Marano, G., Velati, C., Pati, I., Pupella, S., & Liumbruno G.M. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy. Vox Sang. 2021; 116(1), 136-137. https://doi.org/10.1111/vox.12940
  11. Focosi, D., & Franchini, M. COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox Sanguinis. 2021; 116(9), 935-942. https://doi.org/10.1111/vox.13091
  12. Franchini, M., Focosi, D., Casadevall, A., Joyner, M.J., & Perotti, C. Convalescent plasma for COVID-19. TSUNAMI is not the final word. European Journal of Internal Medicine. 2022; 97, 116-118. https://doi.org/10.1016/j.ejim.2022.01.016
  13. Franchini. M., Cruciani, M., Casadevall, A., Joyner, M.J., Senefeld, J.W., Sullivan, D.J., Zani, M., & Focosi, D. Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion. 2023 Dec 29. https://doi.org/10.1111/trf.17701
  14. Sullivan, D.J., Focosi, D., Hanley, D.F., Cruciani, M., Franchini, M., Ou, J., Casadevall, A., & Paneth, N. Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and meta-analysis. Journal of Medical Virology. 2023, 95(12), e29310. https://doi.org/10.1002/jmv.29310
  15. Focosi, D., Meschi, S., Coen, S., Iorio, M.C., Franchini, M., Lanza, M., & Maggi, F. Serum anti-Spike immunoglobulin G levels in random blood donors in Italy: High-titre convalescent plasma is easier than ever to procure. Vox Sanguinis. 2023, 118(9), 794-797. https://doi.org/10.1111/vox.13498
  16. Sullivan, D.J., Franchini, M., Joyner, M.J., Casadevall, A., & Focosi, D. Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources. Nature Communications. 2022; 13(1), 6478. https://doi.org/10.1038/s41467-022-33864-y
Retrieved from ‘https://journal.topitalianscientists.org/index.php?title=Controversies_in_COVID-19_pandemic_the_case_of_convalescent_plasma&oldid=1368’